(2016). Risk of erectile dysfunction associated with use of 5-alpha reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink. Bmj. http://doi.org/10.1136/bmj.i4823
. H. Divan
First name
H.
Middle name
A.
Last name
Divan
(2017). Risk of gynecomastia and breast cancer associated with the use of 5-alpha reductase inhibitors for benign prostatic hyperplasia. Clin Epidemiol. http://doi.org/10.2147/clep.s124674
. (2017). Risk of Incident Antidepressant-Treated Depression Associated with Use of 5alpha-Reductase Inhibitors Compared with Use of alpha-Blockers in Men with Benign Prostatic Hyperplasia: A Population-Based Study Using the Clinical Practice Research Datalink. Pharmacotherapy. http://doi.org/10.1002/phar.1925
.